Financial Results - Xenetic Biosciences, Inc. reported financial results for the three months ended March 31, 2024[6]. - The company issued a press release on May 10, 2024, detailing its business update and financial performance[6]. - The press release is included as Exhibit 99.1, which contains comprehensive financial results for the quarter[9]. Company Classification - The company is classified as an emerging growth company under the Securities Act[5]. Forward-Looking Statements - Forward-looking statements indicate potential risks and uncertainties affecting future performance, including market conditions and regulatory processes[8]. Data Availability - Specific financial metrics and user data were not provided in the extracted content, but the press release is referenced for detailed results[7].
Xenetic Biosciences(XBIO) - 2024 Q1 - Quarterly Results